Parkinsonian Disorders

"Parkinsonian Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Descriptor ID	D020734
MeSH Number(s)	C10.228.140.079.862 C10.228.662.600
Concept/Terms	Parkinsonian Disorders Parkinsonian Disorders Parkinsonian Syndrome Parkinsonism Parkinsonian Syndromes Parkinsonian Diseases Autosomal Dominant Parkinsonism Autosomal Dominant Parkinsonism Dominant Parkinsonism, Autosomal Parkinsonism, Autosomal Dominant Autosomal Recessive Juvenile Parkinson Disease Autosomal Recessive Juvenile Parkinson Disease Chromosome 6-Linked Autosomal Recessive Parkinsonism Chromosome 6 Linked Autosomal Recessive Parkinsonism Familial Parkinson Disease, Autosomal Recessive Juvenile Parkinson Disease, Autosomal Recessive Juvenile Parkinsonism, Autosomal Recessive Parkinsonism, Early Onset, with Diurnal Fluctuation Parkinsonism, Juvenile, Autosomal Recessive Parkinson Disease 2, Autosomal Recessive Juvenile Parkinsonism, Early-Onset, With Diurnal Fluctuation Parkinson Disease, Juvenile, Autosomal Recessive Parkinson Disease 2 Parkinson Disease Autosomal Recessive, Early Onset Autosomal Recesssive Juvenile Parkinsonism Parkinson Disease, Familial, Autosomal Recessive Ramsay Hunt Paralysis Syndrome Ramsay Hunt Paralysis Syndrome Familial Juvenile Parkinsonism Familial Juvenile Parkinsonism Juvenile Parkinsonism, Familial Parkinsonism, Familial Juvenile Parkinsonism, Experimental Parkinsonism, Experimental Experimental Parkinsonisms Parkinsonisms, Experimental Parkinson Disease, Experimental Experimental Parkinsonism, MPTP-Induced Experimental Parkinsonism, MPTP Induced Parkinsonism, MPTP-Induced Experimental MPTP-Induced Experimental Parkinsonism MPTP Induced Experimental Parkinsonism Experimental Parkinson Disease Diseases, Experimental Parkinson Experimental Parkinson Diseases Parkinson Diseases, Experimental Experimental Parkinsonism Parkinsonism, Juvenile Parkinsonism, Juvenile Juvenile Parkinsonism Juvenile Parkinsonisms Parkinsonisms, Juvenile Parkinson Disease, Juvenile Juvenile Parkinson Disease Autosomal Dominant Juvenile Parkinson Disease Autosomal Dominant Juvenile Parkinson Disease Juvenile Parkinson Disease, Autosomal Dominant Parkinsonism, Juvenile, Autosomal Dominant Parkinson Disease, Autosomal Dominant. Juvenile Parkinson Disease, Juvenile, Autosomal Dominant Autosomal Dominant Juvenile Parkinsonism Juvenile Parkinsonism, Autosomal Dominant Autosomal Recessive Parkinsonism Autosomal Recessive Parkinsonism Parkinsonism, Autosomal Recessive Recessive Parkinsonism, Autosomal

Below are MeSH descriptors whose meaning is more general than "Parkinsonian Disorders".

Diseases [C]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Basal Ganglia Diseases [C10.228.140.079]
Parkinsonian Disorders [C10.228.140.079.862]
Movement Disorders [C10.228.662]
Parkinsonian Disorders [C10.228.662.600]

Below are MeSH descriptors whose meaning is more specific than "Parkinsonian Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Parkinsonian Disorders" by people in this website by year, and whether "Parkinsonian Disorders" was a major or minor topic of these publications.

Bar chart showing 38 publications over 21 distinct years, with a maximum of 5 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	1	0	1
2002	3	0	3
2003	2	0	2
2004	2	0	2
2005	2	1	3
2006	3	2	5
2007	4	0	4
2008	2	0	2
2010	3	0	3
2011	0	1	1
2012	1	0	1
2014	1	0	1
2015	1	0	1
2016	1	0	1
2017	0	1	1
2019	1	1	2
2020	1	0	1
2021	1	0	1
2022	1	0	1
2023	1	0	1
2024	1	0	1

Below are the most recent publications written about "Parkinsonian Disorders" by people in Profiles.

Intenzo C, Colarossi D. Invited Commentary: Molecular Imaging of Parkinsonian Syndromes. Radiographics. 2024 02; 44(2):e230233.

View in: PubMed
Dehnavi AZ, Bemanalizadeh M, Kahani SM, Ashrafi MR, Rohani M, Toosi MB, Heidari M, Hosseinpour S, Amini B, Zokaei S, Rezaei Z, Aryan H, Amanat M, Vahidnezhad H, Mohammadi P, Garshasbi M, Tavasoli AR. Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients. Orphanet J Rare Dis. 2023 07 05; 18(1):177.

View in: PubMed
Smeyne RJ, Eells JB, Chatterjee D, Byrne M, Akula SM, Sriramula S, O'Rourke DP, Schmidt P. COVID-19 Infection Enhances Susceptibility to Oxidative Stress-Induced Parkinsonism. Mov Disord. 2022 07; 37(7):1394-1404.

View in: PubMed
Oakes HV, McWethy D, Ketchem S, Tran L, Phillips K, Oakley L, Smeyne RJ, Pond BB. Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism. Neurotox Res. 2021 Jun; 39(3):667-676.

View in: PubMed
Miranda M, Harmuth F, Bustamante ML, Rossi M, Sturm M, Magnusson ?T, Bauer P, Klockgether T, Ramirez A. Intermediate phenotype of ATP13A2 mutation in two Chilean siblings: Towards a continuum between parkinsonism and hereditary spastic paraplegia. Parkinsonism Relat Disord. 2020 12; 81:45-47.

View in: PubMed
Kostuk EW, Cai J, Iacovitti L. Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture. Glia. 2019 08; 67(8):1542-1557.

View in: PubMed
Olsson B, Portelius E, Cullen NC, Sandelius ?, Zetterberg H, Andreasson U, H?glund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, Toledo JB, McBride J, Hernandez-Con P, Lee VM, Trojanowski JQ, Blennow K. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. JAMA Neurol. 2019 03 01; 76(3):318-325.

View in: PubMed
Chang RS, Poon WS. "Triggers" for referral to neurology palliative care service. Ann Palliat Med. 2018 Jul; 7(3):289-295.

View in: PubMed
Isaacson SH, Fisher S, Gupta F, Hermanowicz N, Kremens DE, Lew MF, Marek K, Pahwa R, Russell DS, Seibyl J. Clinical utility of DaTscan? imaging in the evaluation of patients with parkinsonism: a US perspective. Expert Rev Neurother. 2017 03; 17(3):219-225.

View in: PubMed
Chang RS, Leung CY, Leong HS. Bilateral Striatopallidodentate Calcinosis associated with Systemic Lupus Erythematosus: Case report and review of literature. J Neurol Sci. 2015 Nov 15; 358(1-2):518-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement